Literature DB >> 12537040

The family and compliance in schizophrenia: the influence of clinical variables, relatives' knowledge and expressed emotion.

W Sellwood1, N Tarrier, J Quinn, C Barrowclough.   

Abstract

BACKGROUND: . A variety of factors are related to compliance with medication in schizophrenia, but little attention has been paid to the role of families. Carers' knowledge or expressed emotion (EE) may be related to compliance. The aim of the present study was to evaluate the relevance of these two factors, as well as their relationships with other variables for the prediction of compliance.
METHOD: A sample of patient-carer pairs (N = 79) involved in a family intervention for schizophrenia trial was recruited. Compliance, symptoms, social functioning and attitudes to their carers were assessed in patients. Carers' EE, knowledge and psychopathology were also evaluated.
RESULTS: A number of factors were related to compliance, including carers' EE and patients' psychotic symptoms, which contributed independently to not taking medication. Carers' knowledge about schizophrenia and other groups of symptoms was not related to compliance.
CONCLUSIONS: EE may be an important factor to account for in the understanding of patients' compliance and the direction of the relationship between EE and compliance should be the subject of further study.

Entities:  

Mesh:

Year:  2003        PMID: 12537040     DOI: 10.1017/s0033291702006888

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  15 in total

1.  Effects of ethnicity on psychotropic medications adherence.

Authors:  Esperanza Diaz; Scott W Woods; Robert A Rosenheck
Journal:  Community Ment Health J       Date:  2005-10

2.  Family support predicts psychiatric medication usage among Mexican American individuals with schizophrenia.

Authors:  Jorge I Ramírez García; Christina L Chang; Joshua S Young; Steven R López; Janis H Jenkins
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-05-29       Impact factor: 4.328

3.  Predictors of medication non-adherence in Bulgarian outpatients with schizophrenia.

Authors:  Iglika Vassileva; Vihra Milanova; Turan Asan
Journal:  Community Ment Health J       Date:  2014-01-23

4.  The Effects of Psychoeducation on the Expressed Emotion and Family Functioning of the Family Members in First-Episode Schizophrenia.

Authors:  Emine Öksüz; Semra Karaca; Gülten Özaltın; Mehmet Alpay Ateş
Journal:  Community Ment Health J       Date:  2017-01-27

Review 5.  Family intervention for schizophrenia.

Authors:  Fiona Pharoah; Jair Mari; John Rathbone; Winson Wong
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

Review 6.  Defining and assessing adherence to oral antipsychotics: a review of the literature.

Authors:  Dawn I Velligan; Yui-Wing Francis Lam; David C Glahn; Jennifer A Barrett; Natalie J Maples; Larry Ereshefsky; Alexander L Miller
Journal:  Schizophr Bull       Date:  2006-05-17       Impact factor: 9.306

7.  Perceived risk of relapse and role of medication: comparison between patients with psychosis and their caregivers.

Authors:  Kit Wa Sherry Chan; Men Heng Marian Wong; Christy Lai Ming Hui; Edwin Ho Ming Lee; Wing Chung Chang; Eric Yu Hai Chen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-07-24       Impact factor: 4.328

8.  An approach to maximizing treatment adherence of children and adolescents with psychotic disorders and major mood disorders.

Authors:  Robin Edward Gearing; Irfan A Mian
Journal:  Can Child Adolesc Psychiatr Rev       Date:  2005-11

9.  Risk of non-fatal suicide ideation and behaviour in recent onset schizophrenia--the influence of clinical, social, self-esteem and demographic factors.

Authors:  Nicholas Tarrier; Christine Barrowclough; Bernice Andrews; Lynsey Gregg
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-11       Impact factor: 4.328

10.  The noncompliant patient in psychiatry: the case for and against covert/surreptitious medication.

Authors:  K S Latha
Journal:  Mens Sana Monogr       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.